New oral antiviral drug to be used for treatment of COVID-19
Share - WeChat

The National Medical Products Administration has recently granted conditional market approval for an oral antiviral drug RAY1216 in a bid to treat COVID-19.
The drug can be used to treat adults with mild and moderate symptoms of COVID-19, but it must be taken under medical supervision, the administration said.
RAY1216 is a drug developed by Guangdong Zhongsheng Pharmaceutical.
- Hong Kong residents snap up tickets to tour PLA Navy ships
- Domestic, overseas holiday bookings see strong growth
- CPC Central Committee to hold plenum
- Xi: Further adapt religions to Chinese context
- Greece shares flavor of top alcoholic exports at expo
- Holiday travelers urged to give safety top priority